Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Immune cells in cancer
TopicLeading institutions, researchers & key papers
This cluster of papers explores the diverse aspects of macrophage activation and polarization, including their role in tumor microenvironments, interaction with myeloid-derived suppressor cells, modulation of immune responses, and metabolic regulation. The papers cover topics such as monocyte and macrophage heterogeneity, tissue-resident macrophages, and the impact of macrophage plasticity on health and disease.
59,306
Works
1,769,518
Citations
IDs:OpenAlex
How has Immune cells in cancer's publication output changed over time?
ScholarIQpublication output · 2010–2023
Output grew0% over the shown period — from 1 works in 2010 to 1 in 2023.
1
1
2
1
1
20102017201920212023
Who are the most-cited researchers behind Immune cells in cancer?
ScholarIQtop researchers by citations
What are the most-cited papers on Immune cells in cancer?
ScholarIQmost cited works
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin‐Zhi Qian, Jeffrey W. Pollard
Cell. 20105,213 CitationsOPEN ACCESS
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani, Federica Marchesi, Alberto Malesci, Luigi Laghi, Paola Allavena
Nature Reviews Clinical Oncology. 20174,090 Citations
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell. 20233,755 Citations
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw, Lalita A. Shevde
Cancer Research. 20193,464 CitationsOPEN ACCESS
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, Yu Chen, Mingyue Zhou, Yongzhong Wu, Yongsheng Li
Signal Transduction and Targeted Therapy. 20212,757 CitationsOPEN ACCESS
Where is Immune cells in cancer research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Immune cells in cancer is open access?
ScholarIQopen access share
67%OPEN ACCESS
Gold
17%
Green
17%
Hybrid
0%
Bronze
33%
Closed
33%
Who collaborates most closely around Immune cells in cancer?
ScholarIQco-authorship network
Italy
25%
United States
25%
Netherlands
17%
Germany
17%
France
8%